Roche Polska sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-06-14
Share capital
25,000,000.00 PLN
Activity description

Roche Polska focuses on discovering new medicines, diagnostics and digital healthcare solutions. The company develops medicines, therapies and diagnostic solutions, conducts clinical research and has used energy exclusively from renewable sources in its buildings since 2024.

Registered address
ul. Domaniewska 28, 02-672 Warszawa, Poland
Website
Phone
Social media
Electronic delivery address
AE:PL-16840-85351-WCEHU-12

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 366 days for 2023). All were audited by a statutory auditor.

  • 2025not filed
  • 202418/07/2025
  • 202316/07/2025
  • 202225/07/2023
  • 202103/10/2022
  • 202023/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top <1%
Division · Wholesale trade29 / 29,067
Top <1%
Voivodeship · Mazowieckie112 / 142,204
Top <1%
Country · Poland251 / 496,474
Top <1%

Results vs industry

Revenue
This companyUSD 799.69mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 29.26mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 757.22mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 427.42mMedianUSD 610.11kAverageUSD 11.92m

Websites

  • roche.plRoche Polska
    Cloudflare
  • roche.comRoche — Doing now what patients need next
    Cloudflare

Public procurement

1193 tenders recorded as contractor: 192 national ($12,905,823) and 1001 EU ($1,434,003,443).

SubjectAmount
Supply of various medicines, including programme medicines
–
DFP.271.124.2026.JB Supply of medicinal products
$1.9M
Supply of medicines.
$140.4K

Job offers

The company has its own careers page: careers.roche.com.

Authorized Representatives

Ehab Abdelmoneim Youssef-Hassan – President of the Management Board
Adam Artur Krenke age 35 – Attorney-in-fact (joint)
Krzysztof Stanisław Adamcewicz age 64 – Attorney-in-fact (joint)
Ewa Anna Wolińska age 48 – Attorney-in-fact (joint)
Daria Zygmunt Grochal age 37 – Attorney-in-fact (joint)

Manner of representation

Two members of the management board jointly, or one member of the management board together with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Roche Finanz Ag
25,000$6,753,106.43100%

Beneficial owners

Person

Capital group

The company belongs to the Roche Finanz AG (Switzerland) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Apr 30, 2014Return of additional payments

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Komtur Polska sp. z o.o.
Sanofi sp. z o.o.
MSD Polska Dystrybucja sp. z o.o.
Polpharma Biologics S.A.
Bristol-Myers Squibb Polska sp. z o.o.
Accord Healthcare Polska sp. z o.o.
Gilead Sciences Poland sp. z o.o.
Pfizer Polska sp. z o.o.
Ipsen Poland sp. z o.o.
Selvita S.A.

Change history

DateEvent
2023-01-16Address change
2009-02-16Share capital increase
2006-03-07Address change
2002-06-14Entered in the register

FAQ

Last updated: 2026-10-07